Bursipharm lyofilizát na suspenziu pre kurčatá
Bursipharm lyofilizát na suspenziu pre kurčatá
Authorised
- Infectious bursal disease virus, strain Winterfield 2512, Live
Product identification
Medicine name:
Bursipharm lyofilizát na suspenziu pre kurčatá
Active substance:
- Infectious bursal disease virus, strain Winterfield 2512, Live
Target species:
-
Chicken
Route of administration:
-
Inhalation use
-
Oculonasal use
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain Winterfield 2512, Live5.20/log10 tissue culture infective dose 500.10millilitre(s)
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Inhalation use
- Chicken
-
Oculonasal use
- Chicken
-
In drinking water use
- Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Pharmagal Bio spol. s r.o.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/005/01-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 2/12/2021
How useful was this page?:
